🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering substances of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or prison.

Platform Reaction and Content Removal

According to the social media company, the service has taken down violative material and banned related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of entering one group, a seller posted WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these communities, messages show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her team has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject patients to possibly significant medical dangers”.